AGR2: Potential Drug Targets for Cardiovascular Diseases (G10551)

Target Name: AGR2

NCBI ID: G10551

AGR2

AGR2: Potential Drug Targets for Cardiovascular Diseases

AGR2 (short for Angiotensin-converting enzyme 2) is a protein that is expressed in various tissues throughout the body, including the heart, kidneys, and lungs. It is a key enzyme in the regulation of blood pressure and fluid balance, and is involved in the production of angiotensin, a hormone that causes blood vessels to constrict and raise blood pressure.

Research has shown that AGR2 is involved in a wide range of physiological processes in the body, including the regulation of blood pressure, blood flow, and inflammation. It has also been implicated in a number of diseases, including heart failure, hypertension, and diabetes.

Despite its widespread involvement in various physiological processes, little is known about AGR2 and its function in the body. However, studies have shown that AGR2 is involved in the production of angiotensin II, a hormone that causes blood vessels to constrict and raise blood pressure. This is important because high levels of angiotensin II can contribute to the development and progression of heart failure, hypertension, and other cardiovascular diseases.

In addition to its role in the production of angiotensin II, AGR2 is also involved in the regulation of several other physiological processes in the body. For example, it is involved in the production of various enzymes that are involved in the regulation of inflammation and immune response. It is also involved in the regulation of ion channels, which are responsible for the flow of electrical signals through cells.

Given its involvement in so many important physiological processes, AGR2 is a promising drug target. Researchers are currently working to develop new treatments for a range of diseases that are caused by AGR2's dysfunction or abnormal activity. These treatments may include drugs that can inhibit the activity of AGR2, or drugs that can modulate its function in order to improve its regulation of various physiological processes.

In conclusion, AGR2 is a protein that is involved in a wide range of important physiological processes in the body. Despite its widespread involvement, there is still much that is not known about its function in the body. However, studies have shown that AGR2 is involved in the production of angiotensin II, a hormone that can contribute to the development and progression of many cardiovascular diseases. As a result, AGR2 is a promising drug target for a range of diseases.

Protein Name: Anterior Gradient 2, Protein Disulphide Isomerase Family Member

Functions: Required for MUC2 post-transcriptional synthesis and secretion. May play a role in the production of mucus by intestinal cells (By similarity). Proto-oncogene that may play a role in cell migration, cell differentiation and cell growth. Promotes cell adhesion (PubMed:23274113)

The "AGR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AGR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets